| Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci FR Schumacher, AA Al Olama, SI Berndt, S Benlloch, M Ahmed, ... Nature genetics 50 (7), 928-936, 2018 | 808 | 2018 |
| Obesity-related plasma hemodilution and PSA concentration among men with prostate cancer LL Banez, RJ Hamilton, AW Partin, RT Vollmer, L Sun, C Rodriguez, ... Jama 298 (19), 2275-2280, 2007 | 436 | 2007 |
| Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction DV Conti, BF Darst, LC Moss, EJ Saunders, X Sheng, A Chou, ... Nature genetics 53 (1), 65-75, 2021 | 337 | 2021 |
| Comprehensive audiometric analysis of hearing impairment and tinnitus after cisplatin-based chemotherapy in survivors of adult-onset cancer RD Frisina, HE Wheeler, SD Fossa, SL Kerns, C Fung, HD Sesso, ... Journal of Clinical Oncology 34 (23), 2712-2720, 2016 | 268 | 2016 |
| DNA hypermethylation within TERT promoter upregulates TERT expression in cancer DD Lee, R Leao, M Komosa, M Gallo, CH Zhang, T Lipman, M Remke, ... The Journal of clinical investigation 129 (1), 223-229, 2019 | 190 | 2019 |
| The influence of statin medications on prostate-specific antigen levels RJ Hamilton, KC Goldberg, EA Platz, SJ Freedland JNCI: Journal of the National Cancer Institute 100 (21), 1511-1518, 2008 | 185 | 2008 |
| The current evidence on statin use and prostate cancer prevention: are we there yet? MA Alfaqih, EH Allott, RJ Hamilton, MR Freeman, SJ Freedland Nature Reviews Urology 14 (2), 107-119, 2017 | 138 | 2017 |
| Serum miRNA predicts viable disease after chemotherapy in patients with testicular nonseminoma germ cell tumor R Leão, T van Agthoven, A Figueiredo, MAS Jewett, K Fadaak, J Sweet, ... The Journal of urology 200 (1), 126-135, 2018 | 135 | 2018 |
| Statin medication use and the risk of biochemical recurrence after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) Database RJ Hamilton, LL Banez, WJ Aronson, MK Terris, EA Platz, CJ Kane, ... Cancer 116 (14), 3389-3398, 2010 | 135 | 2010 |
| Dissecting the association between metabolic syndrome and prostate cancer risk: analysis of a large clinical cohort B Bhindi, J Locke, SMH Alibhai, GS Kulkarni, DS Margel, RJ Hamilton, ... European urology 67 (1), 64-70, 2015 | 125 | 2015 |
| Shared heritability and functional enrichment across six solid cancers X Jiang, HK Finucane, FR Schumacher, SL Schmit, JP Tyrer, Y Han, ... Nature communications 10 (1), 431, 2019 | 121 | 2019 |
| Cumulative burden of morbidity among testicular cancer survivors after standard cisplatin-based chemotherapy: a multi-institutional study SL Kerns, C Fung, PO Monahan, S Ardeshir-Rouhani-Fard, MI Abu Zaid, ... Journal of Clinical Oncology 36 (15), 1505-1512, 2018 | 121 | 2018 |
| Impact of the US Preventive Services Task Force recommendations against prostate specific antigen screening on prostate biopsy and cancer detection rates B Bhindi, M Mamdani, GS Kulkarni, A Finelli, RJ Hamilton, J Trachtenberg, ... The Journal of urology 193 (5), 1519-1524, 2015 | 118 | 2015 |
| Hidden barriers between knowledge and behavior: the North Carolina prostate cancer screening and treatment experience JA Talcott, P Spain, JA Clark, WR Carpenter, YK Do, RJ Hamilton, ... Cancer: Interdisciplinary International Journal of the American Cancer …, 2007 | 110 | 2007 |
| Developing a highly specific biomarker for germ cell malignancies: plasma miR371 expression across the germ cell malignancy spectrum L Nappi, M Thi, A Lum, D Huntsman, BJ Eigl, C Martin, B O’Neil, ... Journal of clinical oncology 37 (33), 3090-3098, 2019 | 109 | 2019 |
| Multi-institutional assessment of adverse health outcomes among North American testicular cancer survivors after modern cisplatin-based chemotherapy C Fung, HD Sesso, AM Williams, SL Kerns, P Monahan, M Abu Zaid, ... Journal of Clinical Oncology 35 (11), 1211-1222, 2017 | 107 | 2017 |
| Metastatic renal cell carcinoma: Patterns and predictors of metastases—A contemporary population-based series T Chandrasekar, Z Klaassen, H Goldberg, GS Kulkarni, RJ Hamilton, ... Urologic Oncology: Seminars and Original Investigations 35 (11), 661. e7-661 …, 2017 | 102 | 2017 |
| Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants T Dadaev, EJ Saunders, PJ Newcombe, E Anokian, DA Leongamornlert, ... Nature communications 9 (1), 2256, 2018 | 101 | 2018 |
| Cancer stem cells in prostate cancer: implications for targeted therapy R Leão, C Domingos, A Figueiredo, R Hamilton, U Tabori, ... Urologia internationalis 99 (2), 125-136, 2017 | 93 | 2017 |
| Statin use and risk of prostate cancer and high-grade prostate cancer: results from the REDUCE study SJ Freedland, RJ Hamilton, L Gerber, LL Banez, DM Moreira, GL Andriole, ... Prostate cancer and prostatic diseases 16 (3), 254-259, 2013 | 90 | 2013 |
